Mary Cushman: Apply to Shape Scientific Publishing as ISTH Associate Editor
Mary Cushman, President Elect at International Society on Thrombosis and Haemostasis (ISTH), shared International Society on Thrombosis and Haemostasis‘s post on LinkedIn:
” I think you want to be an associate editor for an International Society on Thrombosis and Haemostasis (ISTH) journal!
If you think you might have what it takes, please apply!
Skills needed – solid scientific foundation including methods, publishing track record, ability to commit some time.
The rewards of editing are huge! You get to help shape the science / make it better!
One of the most satisfying experiences of my career!”
International Society on Thrombosis and Haemostasis shared a post on LinkedIn:
“Are you passionate about peer review, scientific publishing and advancing research in thrombosis and hemostasis? Help shape the future international research with the leading ISTH journals in this field! Journal of Thrombosis and Haemostasis (JTH) and RPTH Journal are accepting applications for four Associate Editor positions beginning in January 2027.
Opportunities are available across venous thrombosis, anticoagulant therapy and pharmacology, hemophilia and inherited bleeding disorders, thrombosis and basic science.
Apply by Friday, October 23.
Learn more about the available roles and submit your application.”
Stay updated with Hemostasis Today.
-
Sep 29, 2026, 16:27Scott Isaacs: How GLP-1 RAs Target Systemic Inflammation to Drive Cardio, Autoimmune, and Gut Health
-
Sep 29, 2026, 16:21Yitshak Kreiss: From Treating Patients to Defining the Standard of Knowledge
-
Sep 29, 2026, 16:18Edward Lee Carter: Why Periprocedural DOAC Guidance Needs a Common Output Standard
-
Sep 29, 2026, 16:07Yasmine Laraba: Deep Vein Thrombosis Causes, Signs and Management
-
Sep 29, 2026, 16:01Stephen Cornelissen: How Joining the Stem Cell Registry Can Save Patients with Blood Cancers
-
Sep 29, 2026, 15:45Alan Nurden: Could Mast Cell aIIb Integrin Play a Key Role in Septic Thrombus Stability?
-
Sep 29, 2026, 15:43Priyadarshani Sharma: Advocacy and Patient Rights Transform Indian Haemoglobinopathies Care
-
Sep 29, 2026, 15:21Kanchan K Banerjee: Rusfertide Earns NCCN Category 1 Recommendation for Polycythemia Vera
-
Sep 29, 2026, 15:06Faizan KhanÖ‰ The Worldwide Burden of Venous Thromboembolism